title: Social agonistic distress in male and female mice: changes of behavior and brain monoamine functioning in relation to acute and chronic challenges.
abstract: Stressful events promote several neuroendocrine and neurotransmitter changes that might contribute to the provocation of psychological and physical pathologies. Perhaps, because of its apparent ecological validity and its simple application, there has been increasing use of social defeat (resident-intruder) paradigms as a stressor. The frequency of stress-related psychopathology is much greater in females than in males, but the typical resident-intruder paradigm is less useful in assessing stressor effects in females. An alternative, but infrequently used procedure in females involves exposing a mouse to a lactating dam, resulting in threatening gestures being expressed by the resident. In the present investigation we demonstrated the utility of this paradigm, showing that the standard resident-intruder paradigm in males and the modified version in females promoted elevated anxiety in a plus-maze test. The behavioral effects that reflected anxiety were more pronounced 2 weeks after the stressor treatment than they were 2 hr afterward, possibly reflecting the abatement of the stress-related of hyper-arousal. These treatments, like a stressor comprising physical restraint, increased plasma corticosterone and elicited variations of norepinephrine and serotonin levels and turnover within the prefrontal cortex, hippocampus and central amygdala. Moreover, the stressor effects were exaggerated among mice that had been exposed to a chronic or subchronic-intermittent regimen of unpredictable stressors. Indeed, some of the monoamine changes were more pronounced in females than in males, although it is less certain whether this represented compensatory changes to deal with chronic stressors that could result in excessive strain on biological systems (allostatic overload).
authors.affiliation: Department of Neuroscience, Carleton University, Ottawa, Canada. shulamit76@gmail.com
authors.forename: Shlomit
authors.initials: S
authors.lastname: Jacobson-Pick
authors.forename: Marie-Claude
authors.initials: MC
authors.lastname: Audet
authors.forename: Robyn Jane
authors.initials: RJ
authors.lastname: McQuaid
authors.forename: Rahul
authors.initials: R
authors.lastname: Kalvapalle
authors.forename: Hymie
authors.initials: H
authors.lastname: Anisman
mesh_terms: D000679:Amygdala / Q000378:metabolism; D000818:Animals; D001007:Anxiety / Q000378:metabolism; D001522:Behavior, Animal; D001921:Brain / Q000378:metabolism*; D003345:Corticosterone / Q000097:blood; D005260:Female; D006624:Hippocampus / Q000378:metabolism; D008297:Male; D018782:Maze Learning; D051379:Mice; D009638:Norepinephrine / Q000378:metabolism; D017397:Prefrontal Cortex / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D013315:Stress, Psychological / Q000097:blood / Q000378:metabolism* / Q000628:therapy
chemical_list: D012701:Serotonin; D003345:Corticosterone; D009638:Norepinephrine
references.citation: J Psychopharmacol. 2002 Jun;16(2):115-23
references.pmid: 12095069
references.citation: Neurosci Biobehav Rev. 2011 Apr;35(5):1291-301
references.pmid: 21316391
references.citation: Pharmacol Biochem Behav. 1986 Feb;24(2):323-8
references.pmid: 3952121
references.citation: Neuroscience. 2012 Jul 26;215:114-26
references.pmid: 22542673
references.citation: J Affect Disord. 1993 Oct-Nov;29(2-3):85-96
references.pmid: 8300981
references.citation: Behav Brain Res. 1983 Aug;9(2):129-41
references.pmid: 6603854
references.citation: J Neuroendocrinol. 2006 May;18(5):330-8
references.pmid: 16629831
references.citation: J Neuroinflammation. 2012 Jan 16;9:9
references.pmid: 22248083
references.citation: Physiol Behav. 1975 Jun;14(6):879-81
references.pmid: 1237905
references.citation: Eur J Pharmacol. 1995 Dec 29;294(2-3):531-40
references.pmid: 8750715
references.citation: Behav Brain Res. 2008 Jun 3;189(2):263-72
references.pmid: 18281105
references.citation: Stress. 2010 Jul;13(4):355-64
references.pmid: 20536337
references.citation: Neuroscience. 1997 Dec;81(3):689-97
references.pmid: 9316021
references.citation: Eur J Neurosci. 2004 Jul;20(1):229-39
references.pmid: 15245495
references.citation: Eur J Neurosci. 1998 Dec;10(12):3903-7
references.pmid: 9875367
references.citation: Science. 2006 Feb 10;311(5762):864-8
references.pmid: 16469931
references.citation: J Neurosci. 1999 Jul 1;19(13):5654-65
references.pmid: 10377371
references.citation: Neuropsychobiology. 2005;52(2):90-110
references.pmid: 16037678
references.citation: J Neuroendocrinol. 2007 Oct;19(10):743-51
references.pmid: 17850456
references.citation: Physiol Behav. 2010 Dec 2;101(5):719-25
references.pmid: 20732337
references.citation: Int J Neuropsychopharmacol. 2010 Apr;13(3):361-72
references.pmid: 19545478
references.citation: Horm Behav. 1991 Jun;25(2):206-16
references.pmid: 1648544
references.citation: Neuroscience. 2012 May 17;210:152-67
references.pmid: 22441040
references.citation: Neuroscience. 2012 Aug 30;218:138-53
references.pmid: 22626650
references.citation: Physiol Behav. 2009 Apr 20;97(1):21-9
references.pmid: 19419681
references.citation: Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):226-33
references.pmid: 20050844
references.citation: Physiol Behav. 1993 Feb;53(2):383-8
references.pmid: 8446702
references.citation: Behav Brain Res. 2011 Jan 1;216(1):365-74
references.pmid: 20732357
references.citation: J Neurosci. 2009 Sep 16;29(37):11451-60
references.pmid: 19759294
references.citation: Brain Res. 1992 May 29;581(2):190-7
references.pmid: 1327398
references.citation: Behav Brain Res. 2012 Nov 1;235(1):55-66
references.pmid: 22824590
references.citation: Brain Behav Immun. 2013 Feb;28:149-58
references.pmid: 23164949
references.citation: Horm Behav. 2001 Jun;39(4):247-57
references.pmid: 11374910
references.citation: Cell. 2007 Oct 19;131(2):391-404
references.pmid: 17956738
references.citation: Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4436-41
references.pmid: 20176946
references.citation: Physiol Behav. 2001 Apr;72(5):675-83
references.pmid: 11336999
references.citation: J Neuroendocrinol. 2005 Aug;17(8):526-35
references.pmid: 16011489
references.citation: Nat Neurosci. 2010 Jun;13(6):745-52
references.pmid: 20473292
references.citation: Hippocampus. 2010 Jan;20(1):174-85
references.pmid: 19330847
references.citation: Physiol Behav. 1995 Oct;58(4):669-78
references.pmid: 8559775
references.citation: Pharmacol Ther. 2008 Nov;120(2):102-28
references.pmid: 18789966
references.citation: Int J Neuropsychopharmacol. 2013 Mar;16(2):351-63
references.pmid: 22433238
references.citation: Biol Psychiatry. 2003 Feb 15;53(4):292-303
references.pmid: 12586448
references.citation: PLoS One. 2012;7(8):e44073
references.pmid: 22952879
references.citation: Neuroscience. 1998 Jan;82(1):147-59
references.pmid: 9483511
references.citation: Behav Neurosci. 2001 Apr;115(2):443-54
references.pmid: 11345969
references.citation: Neuropharmacology. 2012 Feb;62(2):565-75
references.pmid: 21396383
references.citation: Behav Brain Res. 2005 Jun 3;161(1):45-59
references.pmid: 15904709
references.citation: Proc Natl Acad Sci U S A. 2012 Oct 16;109 Suppl 2:17180-5
references.pmid: 23045648
references.citation: Eur J Neurosci. 2006 Dec;24(11):3245-54
references.pmid: 17156385
references.citation: Neuroscience. 2008 Mar 27;152(3):573-84
references.pmid: 18295409
references.citation: Eur J Pharmacol. 1987 Sep 23;141(3):347-56
references.pmid: 2822449
references.citation: Behav Brain Res. 2010 Dec 25;214(2):268-76
references.pmid: 20561965
references.citation: Acta Physiol Scand Suppl. 1997;640:69-72
references.pmid: 9401610
references.citation: J Neural Transm (Vienna). 2001;108(3):311-9
references.pmid: 11341483
references.citation: Horm Behav. 2010 Nov;58(5):907-16
references.pmid: 20832411
references.citation: Behav Neural Biol. 1984 Nov;42(2):99-119
references.pmid: 6543117
references.citation: Neuropharmacology. 2005 Feb;48(2):204-14
references.pmid: 15695159
references.citation: Physiol Behav. 2002 Apr 15;75(5):661-73
references.pmid: 12020731
references.citation: Arch Gen Psychiatry. 2009 Jul;66(7):785-95
references.pmid: 19581570
references.citation: Psychopharmacology (Berl). 2012 Nov;224(1):179-88
references.pmid: 22926005
references.citation: J Psychiatr Res. 2010 Jan;44(2):106-11
references.pmid: 19573876
references.citation: J Comp Psychol. 1993 Dec;107(4):373-9
references.pmid: 8112049
references.citation: Curr Top Behav Neurosci. 2012;12:73-138
references.pmid: 22297576
references.citation: Dis Markers. 2011;30(2-3):141-50
references.pmid: 21508518
references.citation: Endocrinology. 2010 Apr;151(4):1784-94
references.pmid: 20185764
references.citation: Psychopharmacology (Berl). 2008 Aug;199(2):231-44
references.pmid: 18491079